🚀 VC round data is live in beta, check it out!
Dentsply Sirona Valuation Multiples
Discover revenue and EBITDA valuation multiples for Dentsply Sirona and similar public comparables like Haemonetics, Inner Mongolia Furui Medical Science, Schott Pharma, Ansell and more.
Dentsply Sirona Overview
About Dentsply Sirona
Dentsply Sirona is one of the world’s largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm’s wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm’s salesforce or directly to consumers (such as the Byte clear aligner).
Founded
1983
HQ
Employees
14.0K
Website
Sectors
Financials (LTM)
EV
$5B
Dentsply Sirona Financials
Dentsply Sirona reported last 12-month revenue of $4B and EBITDA of $651M.
In the same LTM period, Dentsply Sirona generated $2B in gross profit, $651M in EBITDA, and $311M in net income.
Revenue (LTM)
Dentsply Sirona P&L
In the most recent fiscal year, Dentsply Sirona reported revenue of $4B and EBITDA of $667M.
Dentsply Sirona expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | XXX | $4B | XXX | XXX | XXX |
| Gross Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | 52% | XXX | 50% | XXX | XXX | XXX |
| EBITDA | $651M | XXX | $667M | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $311M | XXX | $320M | XXX | XXX | XXX |
| Net Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Dentsply Sirona Stock Performance
Dentsply Sirona has current market cap of $3B, and enterprise value of $5B.
Market Cap Evolution
Dentsply Sirona's stock price is $14.32.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $3B | 0.0% | XXX | XXX | XXX | $1.60 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDentsply Sirona Valuation Multiples
Dentsply Sirona trades at 1.4x EV/Revenue multiple, and 7.6x EV/EBITDA.
EV / Revenue (LTM)
Dentsply Sirona Financial Valuation Multiples
As of April 7, 2026, Dentsply Sirona has market cap of $3B and EV of $5B.
Equity research analysts estimate Dentsply Sirona's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dentsply Sirona has a P/E ratio of 9.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 7.6x | XXX | 7.5x | XXX | XXX | XXX |
| EV/EBIT | 10.0x | XXX | 9.8x | XXX | XXX | XXX |
| EV/Gross Profit | 2.6x | XXX | 2.7x | XXX | XXX | XXX |
| P/E | 9.2x | XXX | 8.9x | XXX | XXX | XXX |
| EV/FCF | 37.7x | XXX | 47.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dentsply Sirona Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Dentsply Sirona Margins & Growth Rates
Dentsply Sirona's revenue in the last 12 month declined by (2%).
Dentsply Sirona's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Dentsply Sirona's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dentsply Sirona's rule of X is 10% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Dentsply Sirona Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (2%) | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | (6%) | XXX | (9%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 10% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 43% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Dentsply Sirona Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Haemonetics | XXX | XXX | XXX | XXX | XXX | XXX |
| Inner Mongolia Furui Medical Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Schott Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Shandong Weigao Blood | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dentsply Sirona M&A Activity
Dentsply Sirona acquired XXX companies to date.
Last acquisition by Dentsply Sirona was on XXXXXXXX, XXXXX. Dentsply Sirona acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Dentsply Sirona
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDentsply Sirona Investment Activity
Dentsply Sirona invested in XXX companies to date.
Dentsply Sirona made its latest investment on XXXXXXXX, XXXXX. Dentsply Sirona invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Dentsply Sirona
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dentsply Sirona
| When was Dentsply Sirona founded? | Dentsply Sirona was founded in 1983. |
| Where is Dentsply Sirona headquartered? | Dentsply Sirona is headquartered in United States. |
| How many employees does Dentsply Sirona have? | As of today, Dentsply Sirona has over 14K employees. |
| Who is the CEO of Dentsply Sirona? | Dentsply Sirona's CEO is Daniel T. Scavilla. |
| Is Dentsply Sirona publicly listed? | Yes, Dentsply Sirona is a public company listed on Nasdaq. |
| What is the stock symbol of Dentsply Sirona? | Dentsply Sirona trades under XRAY ticker. |
| When did Dentsply Sirona go public? | Dentsply Sirona went public in 1983. |
| Who are competitors of Dentsply Sirona? | Dentsply Sirona main competitors are Haemonetics, Inner Mongolia Furui Medical Science, Schott Pharma, Ansell. |
| What is the current market cap of Dentsply Sirona? | Dentsply Sirona's current market cap is $3B. |
| What is the current revenue of Dentsply Sirona? | Dentsply Sirona's last 12 months revenue is $4B. |
| What is the current revenue growth of Dentsply Sirona? | Dentsply Sirona revenue growth (NTM/LTM) is (2%). |
| What is the current EV/Revenue multiple of Dentsply Sirona? | Current revenue multiple of Dentsply Sirona is 1.4x. |
| Is Dentsply Sirona profitable? | Yes, Dentsply Sirona is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dentsply Sirona? | Dentsply Sirona's last 12 months EBITDA is $651M. |
| What is Dentsply Sirona's EBITDA margin? | Dentsply Sirona's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Dentsply Sirona? | Current EBITDA multiple of Dentsply Sirona is 7.6x. |
| What is the current FCF of Dentsply Sirona? | Dentsply Sirona's last 12 months FCF is $132M. |
| What is Dentsply Sirona's FCF margin? | Dentsply Sirona's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Dentsply Sirona? | Current FCF multiple of Dentsply Sirona is 37.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.